Open AccessA human, double-blind, placebo-controlled, crossover trial of prebiotic, probiotic, and synbiotic supplementation: effects on luminal, inflammatory, epigenetic, and epithelial biomarkers of colorectal cancer
Author(s) -
Daniel L. Worthley,
Richard K. Le Leu,
Vicki Whitehall,
Michael A. Conlon,
C. Christophersen,
Damien P. Belobrajdic,
KylieAnn Mallitt,
Ying Hu,
Natsumi Irahara,
Shuji Ogino,
Barbara Leggett,
Graeme P. Young
Publication year - 2009
Publication title -
american journal of clinical nutrition
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.608
H-Index - 336
eISSN - 1938-3207
pISSN - 0002-9165
DOI - 10.3945/ajcn.2009.28106
Subject(s) - prebiotic , lachnospiraceae , colorectal cancer , probiotic , medicine , feces , crossover study , biology , gastroenterology , bifidobacterium , resistant starch , immunology , placebo , lactobacillus , microbiology and biotechnology , cancer , food science , pathology , biochemistry , starch , alternative medicine , bacteria , fermentation , gene , genetics , 16s ribosomal rna , firmicutes
Diet is an important factor in colorectal carcinogenesis; thus, dietary supplements may have a role in colorectal cancer prevention.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom